Implementing Clinical Trials during Epidemics: The Ebola Experience

 
Featuring

Gerald Keusch, Boston University

David Peters, Johns Hopkins University

Discussants

Jeremy Konyndyk, Center for Global Development

Carrie Teicher, Médecins Sans Frontières

Host

Mead Over, Center for Global Development

The 2014-2015 Ebola epidemic broke out and affected thousands of people at a time when there were no medicines approved to treat or prevent Ebola. Poor infrastructure, capacity gaps, widespread mistrust, and disagreements over the design and ethical nature of any clinical trials complicated efforts to conduct research on investigational drugs and vaccines. In the wake of the outbreak, the National Academies of Sciences, Engineering, and Medicine tasked a committee with analyzing the clinical trials carried out during the outbreak and developing recommendations to improve the implementation of such trials in the future. In this session, committee members Gerald Keusch and David Peters will discuss findings from the committee’s recently released report and the kind of governance structures that need to be in place for effective international coordination and collaboration.

Presentation can be accessed here.